Appleton Partners Inc Regeneron Pharmaceuticals, Inc. Transaction History

Appleton Partners Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 03, 2023	SELL	$692.45 - $844.37 $2,077 - $2,533	-3 Reduced 0.33%	907 $746,000
Q2 2022 Jul 08, 2022	SELL	$548.35 - $738.84 $4,386 - $5,910	-8 Reduced 0.87%	910 $538,000
Q1 2022 Apr 05, 2022	SELL	$595.12 - $698.43 $1,785 - $2,095	-3 Reduced 0.33%	918 $641,000
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $500,545 - $617,963	921 New	921 $582,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Appleton Partners Inc with notifications on news.